SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-072991
Filing Date
2010-08-05
Accepted
2010-08-05 09:00:25
Documents
8
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b81582e10vq.htm 10-Q 354264
2 EX-10.1 b81582exv10w1.htm EX-10.1 33774
3 EX-10.2 b81582exv10w2.htm EX-10.2 3805
4 EX-10.3 b81582exv10w3.htm EX-10.3 71437
5 EX-31.1 b81582exv31w1.htm EX-31.1 8124
6 EX-31.2 b81582exv31w2.htm EX-31.2 8391
7 EX-32.1 b81582exv32w1.htm EX-32.1 4532
8 EX-32.2 b81582exv32w2.htm EX-32.2 4266
  Complete submission text file 0000950123-10-072991.txt   490134
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50767 | Film No.: 10992835
SIC: 2834 Pharmaceutical Preparations